Treatment of actinic keratosis (AK) and basal cell carcinoma (BCC) with Metvix (R) (MAL-pdt) in real life practice: A cost of illness and model validation study

Authors
Publication date
1 January 2006
Publisher
'Foundation for Cellular and Molecular Medicine'

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Ghent University Academic Bibliography

    redirect
    oaioai:archive.ugent.be:360247
    Last time updated on 12/11/2016